Ledger.Open graph →
SEC Form D · filed October 14, 2021

Odyssey Therapeutics, Inc

Offering
—
Sold
$91.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MEDFIELD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Carl D. Gordon · MEDFIELD, MADirectorValerie D. Odegard · MEDFIELD, MADirectorGary D. Glick · MEDFIELD, MAExec · DirectorJill D. Carroll · MEDFIELD, MADirectorChuck D. Baum · MEDFIELD, MADirectorCarl D. Gordon · MEDFIELD, MADirectorChuck D. Baum · MEDFIELD, MADirectorValerie D. Odegard · MEDFIELD, MADirectorGary D. Glick · Boston, MAExec · DirectorJill D. Carroll · MEDFIELD, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗